$ Value
—
Shares
4,445
Price
—
Filed
Jul 3
Insider
Name
Garfield Alastair
Title
Chief Scientific Officer
CIK
0002027261
Roles
Transaction Details
Transaction Date
2025-07-01
Code
M
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
4,445
Footnotes
Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. | The sale reported in this Form 4 was effected pursuant to Rule 10b5-1 instruction adopted on June 25, 2024 solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units. | The restricted stock units vest as to 25% of the total restricted stock units on each of the first four anniversaries of July 1, 2024, subject to the Reporting Person's continued service on each such vesting date. The restricted stock units have no expiration date.
Filing Info
Garfield Alastair's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-01 | RYTM | M | — |
| 2026-02-01 | RYTM | F | $221K |
| 2026-02-01 | RYTM | M | $0 |
| 2025-07-02 | RYTM | ▼ | $85K |
| 2025-07-02 | RYTM | ▼ | $388 |
| 2025-07-01 | RYTM | M | — |
| 2025-07-01 | RYTM | M | $0 |
Other Insiders at RYTM (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
German Christopher Paul
Corporate Controller & CAO
|
— | — | 2026-02-01 |
| Popovits Kimberly J | — | — | 2026-04-01 |
|
Meeker David P
President and CEO
|
— | — | 2026-02-01 |
|
Smith Hunter C
Chief Financial Officer
|
— | $703K | 2026-02-05 |
|
Mazabraud Yann
EVP, Head of International
|
— | — | 2026-04-01 |
|
Lee Jennifer Kayden
EVP, Head of North America
|
— | — | 2026-02-01 |
|
Cramer Pamela J.
Chief Human Resources Officer
|
— | — | 2026-02-01 |
|
Shulman Joseph
Chief Technical Officer
|
— | — | 2026-02-01 |
|
Garfield Alastair
Chief Scientific Officer
|
— | — | 2026-02-01 |